Quantcast

Latest pulmonary function testing Stories

2014-06-11 23:10:50

Available in the US in time for Father’s Day, this specially constructed pulmonary harmonica helps improve breathing. No musical talent required, and there’s a coupon code below. Sarasota, FL (PRWEB) June 11, 2014 This year buy something truly useful for the man in your life. Developed for a brother with breathing problems, the Pulmonica is a pulmonary harmonica designed for nonmusicians that exercises the diaphragm and chest muscles to improve breathing. The low tuning is meditative...

2014-05-22 11:31:43

American Thoracic Society Pulmonary function abnormalities may be a precursor to chronic respiratory disease in Iraq/Afghanistan and Gulf War veterans years after their deployment, according to a new study presented at the 2014 American Thoracic Society International Conference. "Previous studies of Gulf War and Iraq/Afghanistan veterans have found persistent respiratory symptoms decades after their deployment but have not always detected clinically significant pulmonary abnormalities,"...

healthy diet for COPD
2014-05-22 07:32:40

April Flowers for redOrbit.com - Your Universe Online An international team of researchers has discovered a direct link between eating fish, fruit and dairy products with improved lung function in patients with chronic obstructive pulmonary disease (COPD). The study, which is being presented at the American Thoracic Society (ATS) 2014 International Conference, specifically examined COPD patients' lung function within 24 hours of consuming fish, cheese, grapefruit and bananas. "Diet is a...

2014-05-09 13:07:48

University of Illinois By simply carrying around their cellphones, patients who suffer from chronic disease could soon have an accurate health monitor that warns their doctors when their symptoms worsen. GaitTrack, an app developed by researchers at the University of Illinois at Urbana-Champaign and the U. of I. at Chicago, turns a smartphone into a sophisticated medical device. Unlike other apps that merely count steps, GaitTrack uses eight motion parameters to perform a detailed...

2014-05-07 08:32:19

WARRINGTON, Pa., May 7, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent and Notices of Allowance for patents covering critical aspects of its KL4 surfactant and drug delivery technology platform. The Company announced the issuance of U.S. Patent No. 8,701,658 entitled...

2014-05-06 08:34:07

WARRINGTON, Pa., May 6, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will report first quarter 2014 financial results on May 8, 2014 before the open of the U.S. financial markets. The Company will host a live teleconference and webcast at 9:00 a.m. Eastern Time that same day. During the conference call, Discovery Labs' management will discuss the 2014 first...

2014-04-30 20:23:46

LONDON, April 30, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Incruse(TM) Ellipta(®) (umeclidinium) as an anticholinergic indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Umeclidinium is GSK's first once-daily anticholinergic, a type of...

2014-04-30 12:30:17

- First results of the pivotal Phase 3 INPULSIS(TM) trials investigating the efficacy and safety of nintedanib, an investigational compound, in the treatment of idiopathic pulmonary fibrosis (IPF) RIDGEFIELD, Conn., April 30, 2014 /PRNewswire/ -- Boehringer Ingelheim announced today that the first results from two highly anticipated Phase 3 trials in idiopathic pulmonary fibrosis (IPF) and in chronic obstructive pulmonary disease (COPD) will be presented at the 2014 American...

2014-04-28 08:32:52

RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., April 28, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that Anoro(TM) Ellipta(®) (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies...

2014-03-11 08:29:57

WARRINGTON, Pa., March 11, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will report fourth quarter 2013 financial results on Thursday, March 13, 2014 before the open of the U.S. financial markets. The Company will host a conference call and live audio webcast at 10:00 a.m. Eastern Time that same day. During the conference call, Discovery Labs' management will...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related